SLC8A3 and brain ischemia: We identified two novelmodulators of NCX: compound 4, inhibiting NCX1 reversemode, and compound 14, enhancing NCX1 and NCX3 activity.Compound 1 displayed neuroprotection in two preclinicalmodels of brain ischemia.